Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-15-075470
Filing Date
2015-10-14
Accepted
2015-10-14 17:58:15
Documents
1
Period of Report
2015-10-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3956
  Complete submission text file 0001209191-15-075470.txt   5353
Mailing Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710
Business Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710 5108485100
DYNAVAX TECHNOLOGIES CORP (Issuer) CIK: 0001029142 (see all company filings)

EIN.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O INTERWEST PARTNERS 2710 SAND HILL ROAD, 2ND FLOOR MENLO PARK CA 94025
Business Address
ORONSKY ARNOLD L (Reporting) CIK: 0001207833 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34207 | Film No.: 151158857